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Abstract
Background—Antihypertensive medication use has been associated with an increased risk of 
falls in some but not all studies. Few data are available on the short-term risk of falls following 
antihypertensive medication initiation and intensification.
Methods and Results—We examined the association between initiating and intensifying 
antihypertensive medication and serious fall injuries in a case-crossover study of 90,127 Medicare 
beneficiaries who were ≥65 years old and had a serious fall injury between July 1, 2007 and 
December 31, 2012, based on emergency department and inpatient claims. Antihypertensive 
medication initiation was defined by a prescription fill with no fills in the prior year. 
Intensification was defined by the addition of a new antihypertensive class, and, separately, 
titration by the addition of a new class or increase in dosage of a current class. Exposures were 
ascertained for the 15 days before the fall (case period) and six 15-day earlier periods (control 
periods). Overall, 272, 1508, and 3113 Medicare beneficiaries initiated, added a new class of 
antihypertensive medication or titrated therapy, respectively, within 15 days of their serious fall 
injury. The odds for a serious fall injury was increased during the 15 days following 
antihypertensive medication initiation [odds ratio, OR, 1.36 (95% CI 1.19, 1.55)], adding a new 
class [OR 1.16 (95% CI 1.10, 1.23)], and titration [OR 1.13 (95% CI 1.08, 1.18)]. These 
associations were attenuated beyond 15 days.
Conclusions—Antihypertensive medication initiation and intensification was associated with a 
short-term, but not long-term, increased risk of serious fall injuries among older adults.
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The benefit of antihypertensive medication on cardiovascular disease (CVD) risk reduction 
has been demonstrated among older adults in randomized controlled trials.1–3 However, 
there may be unintended harm associated with antihypertensive medication use in older 
adults.4–7 Older adults are susceptible to adverse side effects associated with 
antihypertensive medication use including postural hypotension, balance and gait 
impairment, dizziness, and electrolyte disturbances,8–10 which may increase the risk of 
serious fall injuries. Clinicians often weigh the CVD risk-reduction benefits of 
antihypertensive medications against their potential for inducing fall injuries among older 
adults.
Some, but not all, studies suggest that antihypertensive medication use in older adults is 
associated with an increased risk for falls or injuries related to falls including 
fractures.4–7,11,12 As most studies have examined prevalent users of antihypertensive 
medication, the relevance of these findings to clinical decision-making regarding 
antihypertensive medication initiation or intensification is limited. Also, few data are 
available on the short-term vs. long-term risk for falls after initiation or intensification of 
antihypertensive medication.7 Determining whether antihypertensive medication initiation or 
intensification is associated with an increased risk for serious fall injuries, and identifying a 
hazard period associated with increased risk have important implications given the large 
number of older adults initiating and titrating antihypertensive medication13 and the 
availability of preventive strategies to reduce falls risk.14 We determined whether 
antihypertensive medication initiation is associated with a short-term increased risk for a 
serious fall injury among older US adults, and whether the risk for a serious fall injury is 
similarly increased after antihypertensive medication intensification. We also examined the 
long-term fall injury risk following antihypertensive medication initiation and 
intensification.
Methods
We conducted two types of analyses using a national 5% random sample of Medicare 
beneficiaries from 2006 through 2012. The first analysis was a retrospective cohort study, 
which was used to estimate the absolute risk for serious fall injuries among beneficiaries 
initiating, adding a new antihypertensive medication class or titrating antihypertensive 
medication. The second analysis was a case-crossover study of Medicare beneficiaries who 
experienced a serious fall injury. The case-crossover study was used to determine if 
initiating, adding a new class or titrating antihypertensive medication were associated with 
an increased risk for serious fall injuries. Data used for the current analyses include claims 
from Medicare fee-for-service Parts A (inpatient), B (outpatient) and D (prescription drug). 
Institutional review boards at the University of Alabama at Birmingham and the Center for 
Medicare and Medicaid Services approved this analysis.
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Medicare beneficiaries who initiated antihypertensive medication between January 1, 2007 
and December 31, 2011 were included in the retrospective cohort used to estimate the 
absolute risk for serious fall injuries in the 15 days following initiation, adding a new class 
and titration of treatment (Supplemental Figure 1). Initiation was defined by a Medicare Part 
D claim for antihypertensive medication with 365 continuous days of Medicare fee-for-
service coverage (Parts A, B, and D but not C) prior to the fill with no claims for 
antihypertensive medication. Medicare beneficiaries enrolled in a managed care program 
(Part C) during this time period were not included as this is a capitated program and claims 
for these individuals are not complete. The date of the antihypertensive medication fill is 
provided with the claim. All medication classes filled within the 7 days following the date of 
initiation were included as part of the initiation regimen.15 We restricted the sample to 
beneficiaries with hypertension, defined by one or more outpatient physician evaluation and 
management claims with International Classification of Diseases, 9th Revision (ICD-9) 
diagnoses of 401.x (malignant, benign or unspecified essential hypertension) during the 365 
days prior to each beneficiary’s first fill. We included Medicare beneficiaries with age ≥ 65 
years old and < 110 years old at the start of the look-back period (365 days prior to the first 
antihypertensive medication fill), and having continuous residence in the US during the 
look-back period, to provide information for the general population of older US adults. 
Adding a new class of antihypertensive medication was defined by a Medicare Part D claim 
for a class of antihypertensive medication other than those filled upon initiation. Titration 
was defined by adding a new class of antihypertensive medication or an increase in the 
dosage of the medication class filled upon initiation. Adding a new antihypertensive 
medication class and titration were studied in the 365 days following initiation. Therefore, 
for these analyses, follow-up occurred through December 31, 2012.
Case-crossover Study
The case-crossover study design is useful for investigating the transient effect of an 
exposure.16–18 Using this study design, only individuals who experience an outcome are 
analyzed and each case serves as their own control. Medicare beneficiaries who experienced 
a serious fall injury event between July 1, 2007 and December 31, 2012 formed the base 
population for these analyses (Supplemental Figure 2). We used International Classification 
of Diseases, Ninth Edition, Clinical Modification (ICD-9-CM) and current procedure 
terminology (CPT) codes to identify these events. Serious fall injuries were defined as 
emergency department and inpatient claims with a fall-related E code (8800–8889) and an 
injury code for nonpathological skull, facial, cervical, clavicle, humeral, forearm, pelvic, 
hip, fibula, tibia, or ankle fractures (80000–80619, 8070–8072, 8080–8089, 81000–81419, 
8180–8251, or 8270–8291), brain injury (85200–85239), or dislocation of the hip, knee, 
shoulder, or jaw (8300–8321, 83500–83513, or 83630–83660).6 In the absence of a fall-
related E code, an emergency department or inpatient claim with any of these codes was 
considered a serious fall injury as long as there was no motor vehicle accident E code 
(8100–8199).6 We required all beneficiaries to have at least 560 days of continuous 
Medicare fee-for-service coverage preceding the date of their serious fall injury. As 
described below, the 560-day interval includes the 195-day period (days 0–194) between the 
index date and the start of the earliest control period, and a 365-day period (days 195–559) 
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prior to the earliest control period, which was used for assessing antihypertensive medication 
use and clinical characteristics. We restricted the population to Medicare beneficiaries with 
age ≥ 65 years old and < 110 years old 560 days prior to their fall injury, and having 
continuous residence in the US during the 560 days prior to their fall injury. For each 
beneficiary, we included the first occurrence of a serious fall injury meeting the above 
criteria. The date of the serious fall injury diagnosis was assigned as the index date.
The primary exposure was the initiation of antihypertensive medication. The case period was 
defined as the 15 days prior to and including the index date (days 0–14) and we selected six 
15-day control periods (30 to 44, 60 to 74, 90 to 104, 120 to 134, 150 to 164, and 180 to 194 
days prior to the index date). A schematic of this study design is presented in Figure 1. For 
the case period and each control period, initiation of antihypertensive medication was 
defined by a claim in Medicare Part D for an angiotensin converting enzyme (ACE)-
inhibitor, aldosterone antagonist, angiotensin receptor blocker (ARB), alpha blocker, beta 
blocker, calcium channel blocker, central acting agent, diuretic (thiazide-type, loop or 
potassium sparing), renin inhibitor, or vasodilator with no claims for any of these medication 
classes during the 365 days prior to the first antihypertensive medication fill. These drugs 
were identified using National Drug Codes (NDC).
The risk for serious fall injuries associated with two secondary exposures representing 
antihypertensive medication intensification was examined: (1) addition of a new class of 
antihypertensive medication, and alternatively (2) antihypertensive medication titration. 
Addition of a new class of antihypertensive medication was defined as a fill for a class of 
antihypertensive medication within the case period or, separately, the control periods with no 
fills for that drug class during the preceding 365 days. Medication titration was defined as 
the addition of a new class of antihypertensive medication or an increase in the dosage of a 
medication class during the case or control periods.
Characteristics of Medicare Beneficiaries
Age, race/ethnicity, sex, region of residence, and calendar month of the fall were obtained 
from the Medicare beneficiary summary file. Using previously published algorithms,19–25 
we identified a history of diabetes, coronary heart disease, heart failure, stroke, chronic 
kidney disease, syncope, osteoporosis, depression, or dementia. Additionally, based on Part 
D claims and NDCs, the number of different generic medications, besides antihypertensive 
medications, that each beneficiary filled was determined. The Charlson score, a measure of 
overall co-morbidity, was calculated.26 Additionally, a skilled nursing facility stay and any 
hospitalizations was identified in Medicare claims. These characteristics were identified at 
the time of at initiation of antihypertensive medication for the retrospective cohort study; 
and on the 365 days prior to the index date for the case-crossover study.
Statistical Analysis
For the retrospective cohort study, we calculated the percentage of Medicare beneficiaries 
experiencing a serious fall injury within 15 days after antihypertensive medication initiation. 
Among Medicare beneficiaries who initiated antihypertensive medication, characteristics at 
the time of initiation were calculated for those who experienced and did not experience a 
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serious fall injury within 15 days. We then calculated the percentage of Medicare 
beneficiaries experiencing a serious fall injury within 15 days after adding a new 
antihypertensive medication class and medication titration.
For the case-crossover study, the characteristics of all Medicare beneficiaries who 
experienced a serious fall injury and those who experienced a serious fall injury within 15 
days following initiation of antihypertensive medication were calculated. The distribution of 
classes of antihypertensive medication that were initiated in the 15-day case period and the 
six control periods were calculated for the overall sample and among Medicare beneficiaries 
with one or more diagnoses of hypertension. As some drugs, classified as antihypertensive 
medication, may be prescribed for indications other than hypertension, sensitivity analyses 
were conducted in which the definitions of initiation, addition of a new antihypertensive 
medication class, and antihypertensive medication titration also required having one or more 
diagnoses of hypertension (International Classification of Diseases, 9th Revision [ICD-9] 
diagnoses of 401.xx) in the 365 days prior to the case or control period. Further, as being 
hospitalized could result in an increased risk for falls and may be associated with initiation 
of antihypertensive medication, sensitivity analyses were conducted after excluding 
beneficiaries who were hospitalized in the 365 days prior to their serious fall injury. The 
odds ratio and 95% confidence interval (95% CI) for a serious fall injury associated with 
initiation of antihypertensive medication in the case period (0–14 days prior to the fall) were 
calculated using conditional logistic regression accounting for each beneficiary having six 
control periods (Table 1). Analyses were repeated using one (60 to 74 days prior to the fall) 
instead of six control periods. Cumulative mortality through 90 days after having a serious 
fall injury was determined. To assess the longer-term effects of initiating antihypertensive 
medication on risk for serious fall injuries, we calculated odds ratios (95% CI) using three 
alternate case and multiple control periods for each case period prior to the index date (i.e. 
date of the serious fall injury) (Table 1). Analyses were also repeated using one control 
period for each of the 3 case periods.
In exploratory analyses, odds ratios (95% CI) for a serious fall injury were also calculated 
within pre-specified subgroups defined by demographics and the presence of medical co-
morbidities, which are associated with an increased risk of falls.27,28 Some studies have 
suggested that specific classes of antihypertensive medication are associated with a higher 
risk of falls or fractures.4,29 Further, the majority of older US adults on antihypertensive 
medication are taking 2 or more classes.6 Therefore, pre-specified analyses were also 
conducted for subgroups defined by antihypertensive medication class and also the number 
of antihypertensive medication classes. Differences across subgroups were calculated using 
multiplicative interaction terms.
The case-crossover analyses were repeated to assess the association between adding a new 
class of antihypertensive medication and antihypertensive medication titration and the odds 
ratios for serious fall injuries. Analyses were conducted using SAS Version 9.3 (SAS 
Institute, Cary, NC).
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Risk for Serious Fall Injuries in the Retrospective Cohort Study
Between January 1, 2007 and December 31, 2011, 65,210 Medicare beneficiaries who met 
the inclusion criteria initiated antihypertensive medication. Of this population, 186 (0.29%) 
Medicare beneficiaries had a serious fall injury within 15 days following treatment initiation. 
Beneficiaries who initiated antihypertensive medication and had a serious fall injury within 
15 days were older; less likely to be male; more likely to have a history of coronary heart 
disease, heart failure, stroke, syncope, osteoporosis, depression, and dementia; and were 
taking more medication classes, have a higher Charlson comorbidity index, and be 
hospitalized or in a skilled nursing facility in the prior year (Supplemental Table 1). Within 
365 days following antihypertensive medication initiation, 23,315 and 30,143 beneficiaries 
added a class of antihypertensive medication and titrated their antihypertensive medication, 
respectively. A serious fall injury occurred within 15 days after adding a new class of 
antihypertensive medication for 0.27% (n=64) of beneficiaries and within 15 days after 
titration for 0.29% (n=88) of beneficiaries.
Short-term Risk of Serious Fall Injuries Associated with Antihypertensive Medication in 
the Case-crossover Study
Table 2 shows the characteristics of the 90,127 Medicare beneficiaries who had a serious fall 
injury between January 1, 2007 and December 31, 2012 and of the subset of 272 individuals 
who initiated antihypertensive medication in the 15 days prior to their fall. Of those 
initiating antihypertensive medication, 30.9%, 34.6%, and 34.6% were aged 65 to 74, 75 to 
84, and ≥ 85 years, respectively; 28.3% were male; and 89.7% were white.
Overall, 272, 1,508, and 3,113 Medicare beneficiaries initiated, added a new class of 
antihypertensive medication, and titrated therapy, respectively, within 15 days prior to their 
serious fall injury. The short-term odds ratios (95% CI) for a serious fall injury were 1.36 
(95% CI 1.19, 1.55) for initiation of antihypertensive medication, 1.16 (95% CI 1.10, 1.23) 
for adding a new antihypertensive medication class, and 1.13 (95% CI 1.08, 1.18) for 
antihypertensive medication titration (Table 3). The associations were similar when the 
definition of antihypertensive medication initiation, addition, and titration required one or 
more diagnoses of hypertension, and when the population was restricted to Medicare 
beneficiaries without a recent hospitalization. The associations were similar using one 
control period (Supplemental Table 2). Among Medicare beneficiaries with a serious fall 
injury within 15 days following antihypertensive medication initiation, addition of new 
class, and titration, 14.0%, 15.6 %, and 14.6%, respectively, died within 90 days following 
the fall.
Antihypertensive Medication Class Initiated in Case vs. Control Periods
Initiation of diuretics, particularly loop diuretics, was more common in the 15-day case 
period compared to the control periods (Supplemental Table 3). Initiation with other classes 
of antihypertensive medication was similar in the case and control periods. The percentage 
of beneficiaries who simultaneously initiated more than one antihypertensive class was 
higher in the case period (20.2%) compared with the control periods (17.4%). These results 
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were similar when the definition of antihypertensive medication initiation required one or 
more diagnoses of hypertension, and when the population was restricted to Medicare 
beneficiaries without a recent hospitalization
Subgroup Analyses
The association between antihypertensive medication initiation and serious fall injuries did 
not vary by subgroup (Supplemental Table 4). The short-term odds ratio for a serious fall 
injury associated with the addition of a new class of antihypertensive medication was 
stronger for Medicare beneficiaries without a history of diabetes, without heart failure, and 
who were taking fewer non-antihypertensive medications (Supplemental Table 5). The short-
term odds ratio for a serious fall injury associated with the titration of antihypertensive 
medication was stronger for older Medicare beneficiaries, those without a history of heart 
failure, and without chronic kidney disease (Supplemental Table 6). The associations of 
initiation and addition of antihypertensive medication with serious fall injuries did not vary 
by medication class or the number of classes initiated (Supplemental Table 7) or added 
(Supplemental Table 8).
Long-term Risk of Serious Fall Injuries
No association was present between initiating antihypertensive medications, and, separately, 
adding a new class of antihypertensive medication in the 30–44 days, 60–74 days, or 90–104 
days prior to a fall, and the risk for a subsequent fall injury (Table 4). The odds ratio for a 
serious fall injury associated with the titration of antihypertensive medication within 30–44 
days, 60–74 days, and 90–104 days prior to the fall was 1.04 (95% CI 1.00, 1.09), 1.05 (95% 
CI 1.00, 1.09) and 1.04 (95% CI 1.00, 1.09), respectively. The associations were similar in 
analyses using one instead of six control periods (Supplemental Table 9).
Discussion
Falls risk among elderly individuals is a major public health concern.30 Falls are often 
attributed to the interaction of long-term predisposing conditions and short-term 
precipitating factors.27,31 The high rate of falls and risk for adverse outcomes following a 
fall has generated an increasing recognition of the need to identify precipitating factors for 
falls in older adults.14 In the current study, the odds for a serious fall injury were increased 
in the 15 days after antihypertensive medication initiation and intensification. An increased 
risk for a serious fall injury was no longer present more than 15 days after either initiation or 
adding a new class, and was attenuated more than 15 days after titration of antihypertensive 
medication.
Prior studies of the short-term risks following antihypertensive medication initiation have 
focused on fractures as an outcome rather than the risk of falls or injuries related to 
falls.4,5,12,32 For example, Butt et al.5 showed that hip fracture risk was increased in the 45 
days after antihypertensive medication initiation among Ontario residents who were 66 years 
and older. Initiation of ACE inhibitors and beta blockers were each significantly associated 
with an increased risk of hip fractures, whereas thiazide diuretics, ARBs, and calcium 
channel blockers were not. In the current study, an increased odds ratio for a serious fall 
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injury was present when antihypertensive medication was initiated in a 15-day period prior 
to the fall, but not beyond 15 days. This association did not vary by the class of 
antihypertensive medication initiated.
Scarce data are available on the association between antihypertensive medication 
intensification and the risk of a serious fall injury. In a substudy of 3,099 middle age and 
older participants with diabetes enrolled in the Action to Control Cardiovascular Risk in 
Diabetes (ACCORD) trial, Margolis et al.11 did not find an increased risk for self-reported 
falls or non-spine fractures between participants randomized to a systolic pressure of less 
than 120 mmHg, vs. systolic pressure of less than 140 mmHg. It is unclear whether these 
results are applicable for older adults who undergo antihypertensive medication 
intensification, as the ACCORD substudy participants were relatively young (mean age 62 
years old) and the outcomes were ascertained years after reductions in blood pressure had 
occurred in the intensive treatment arm. In the current study, there was no long-term 
increased risk for serious falls injuries associated with antihypertensive medication use, a 
finding that is consistent with the findings from ACCORD.11
The Systolic Blood Pressure Intervention Trial (SPRINT) recently demonstrated that a 
systolic blood pressure target goal of 120 mmHg (intensive treatment) versus 140 mmHg 
(conventional treatment) was associated with a lower risk of CVD events and mortality in 
adults at least 50 years of age with a systolic blood pressure of 130 to 180 mm Hg and high 
cardiovascular risk, but without diabetes or a prior stroke.3 The intensive versus 
conventional treatment goal was associated with a higher risk of hypotension, syncope, 
electrolyte abnormalities, but not injurious falls, defined as falls that resulted in evaluation in 
an emergency department or hospitalization. However, when adverse events were classified 
as possibly or definitely related to intensive treatment, the risk of injurious falls was higher 
in the intensive vs. conventional treatment arm (0.8% versus 0.5%, p=0.05). The results from 
the current study indicating a short-term increased risk of serious fall injuries after 
antihypertensive medication intensification but no increased risk with long-term 
antihypertensive medication use are consistent with the findings in SPRINT. It was reported 
that 7.6% or 16.8 million of US adults meet the SPRINT eligibility criteria.33 Therefore, 
many older US adults may have their antihypertensive medication intensified to reach a 
lower systolic blood pressure target, and be susceptible to a short-term increased risk of 
serious fall injuries.
Some, but not all, studies have reported that antihypertensive medication use in older adults 
is associated with an increased risk for falls or fall injuries injuries.4–7,11,12 Tinetti et al.6 
conducted a retrospective cohort study and found that in clinical practice, Medicare 
beneficiaries older than 70 years of age who were taking antihypertensive medication had a 
higher risk of a serious fall injury than their counterparts not taking antihypertensive 
medication. Using a case-crossover study design, which minimizes confounding by having 
each individual serve as his/her own control, we have extended the results of Tinetti et al.6 to 
demonstrate that antihypertensive medication initiation and intensification may be associated 
with a short-term increased risk of serious fall injuries in older adults.
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Using a retrospective cohort study design, we also showed that the risk of a serious fall 
injury was low within 15 days after initiating antihypertensive medication, adding a new 
class, and titrating antihypertensive medication. However, the risk for a fall after 
antihypertensive initiation and intensification is likely to be substantially higher, as serious 
fall injuries represent only 10% of all falls experienced by older adults.27,34 Serious fall 
injuries including fractures, brain injuries, and dislocations are the most adverse 
consequences of falls in older adults. Nonetheless, falls that do not result in a serious injury 
are also clinically important as they are associated with functional decline and nursing home 
placement in older adults.35,36
There are several potential mechanisms for the short-term increased risk of serious falls 
associated with antihypertensive medication initiation and intensification. Older adults are at 
increased risk for postural hypotension,37,38 which may result in neurologic effects and 
consequently balance and gait impairment. In addition, antihypertensive medication-induced 
electrolyte disturbances may cause neurologic and physical side effects, which may make 
older adults more susceptible to falls.9,10,39,40 Multicomponent interventions that include 
multiple risk factor assessment, physical therapy, and exercise are effective in falls 
prevention.14,41 These strategies could be adopted by clinicians in the short-term to prevent 
falls and fall-related injuries when antihypertensive medication is initiated or intensified in 
their older patients.
There are several strengths of the current study. Given the longitudinal nature of Medicare 
claims, we were able to study serious injuries after antihypertensive medication initiation 
and intensification. Another strength of the study is that Medicare provides data that are 
highly generalizable to older adults in the US. Some limitations must be noted. The 
generalizability to younger adults may be limited. Also, as with all claims-based analyses, 
the results depend on the accuracy of coding of disease states and pharmacy fills. As blood 
pressure data are not available in Medicare claims, we could not determine whether the 
associations we report can be explained by changes in blood pressure levels. As there was a 
lack of information on falls that did not result in a serious injury, we could not determine 
whether antihypertensive medication initiation or intensification was associated with less 
serious falls. Another potential limitation is the assumption that clinical characteristics were 
stable over time in the case-crossover study. Given that the duration between the control 
periods and the case period was relatively short (195 days or less), it is likely that substantial 
changes in clinical characteristics did not occur. It was not possible to determine the exact 
timing between antihypertensive medication initiation and intensification and the occurrence 
of the serious fall injury using Medicare claims. However, the inability to pinpoint the 
timing of the outcome and the appropriate time window for the exposure will likely bias 
results toward the null.42,43 Therefore, if the exact time course were known, the associations 
of antihypertensive medication initiation and intensification with the risk of serious fall 
injuries would be even stronger. Finally, although the case-crossover study demonstrated that 
antihypertensive medication initiation and intensification are associated with an increased 
risk of serious fall injuries, caution is warranted when concluding the results indicate 
causality.
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In conclusion, the results of the current study indicate that the initiation and intensification 
of antihypertensive medication are associated with a short-term increased risk of a serious 
fall injury in older adults. However, the short-term risk of a serious fall injury is low, and 
there does not appear to be a long-term increased risk for serious fall injuries associated with 
antihypertensive medication. The short-term risk of serious fall injuries as well as 
approaches for reducing this risk should be discussed with older patients when initiating or 
intensifying antihypertensive medication.
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• In older adults, antihypertensive medication use has been associated with an 
increased risk of falls in some but not all studies.
• Few data are available on the short-term vs. long-term risk for falls after 
initiation or intensification of antihypertensive medication in older adults.
What the Study Adds
• Using Medicare claims from 2007 through 2012, we found that although the risk 
of a serious fall injury was low, there was a short-term increased risk of a serious 
fall injury within a 15-day period after initiation or intensification of 
antihypertensive medication.
• In contrast, the association between antihypertensive medication initiation or 
intensification and a serious fall injury was attenuated beyond 15 days.
• The results of this study suggest that antihypertensive medication initiation and 
intensification was associated with a short-term, but not long-term, increased 
risk of serious fall injuries among older adults.
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Schematic of the case-crossover study design. For the case and each 15-day control period, 
separately, the initiation of antihypertensive medication was defined as a fill within the time 
period with no antihypertensive medication fills during the 365 days prior to the first 
antihypertensive medication fill.
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Table 1
Case and control periods used in assessing the odds ratio for a serious fall injury associated with initiation, 
adding a new drug class, and antihypertensive medication titration.




Analysis of short-term risk for serious fall injuries
0 to 14 days Six control periods
30 to 44 days
60 to 74 days
90 to 104 days
120 to 134 days
150 to 164 days
180 to 194 days
One control period
60 to 74 days
Analysis of long-term risk for serious fall injuries
30 to 44 days Five control periods
60 to 74 days
90 to 104 days
120 to 134 days
150 to 164 days
180 to 194 days
One control period
90 to 104 days
60 to 74 days Four control periods
90 to 104 days
120 to 134 days
150 to 164 days
180 to 194 days
One control period
120 to 134 days
90 to 104 days Three control periods
120 to 134 days
150 to 164 days
180 to 194 days
One control period
150 to 164 days
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Table 2
Characteristics of Medicare beneficiaries experiencing a serious fall injury between July 1, 2007 and 






in case period (N=272)
Age on fall date
  <75 years 23,392 (26.0%) 84 (30.9%)
  75 –84years 35,209 (39.1%) 94 (34.6%)
  ≥ 85 years 31,526 (35.0%) 94 (34.6%)
Male sex 21,499 (23.9%) 77 (28.3%)
Race/ethnicity
  White 80,567 (89.4%) 244 (89.7%)
  African American 4,341 (4.8%) 12 (4.4%)
  Other 5,219 (5.8%) 16 (5.9%)
Region
  Northeast 17,999 (20.0%) 47 (17.3%)
  Midwest 22,968 (25.5%) 69 (25.4%)
  South 34,673 (38.5%) 110 (40.4%)
  West 14,487 (16.1%) 46 (16.9%)
Calendar month of fall
  January 7,190 (8.0%) 22 (8.1%)
  February 6,538 (7.3%) 23 (8.5%)
  March 6,854 (7.6%) 15 (5.5%)
  April 6,721 (7.5%) 24 (8.8%)
  May 6,860 (7.6%) 19 (7.0%)
  June 6,737 (7.5%) 21 (7.7%)
  July 7,560 (8.4%) 27 (9.9%)
  August 7,966 (8.8%) 21 (7.7%)
  September 7,964 (8.8%) 23 (8.5%)
  October 8,237 (9.1%) 23 (8.5%)
  November 8,212 (9.1%) 24 (8.8%)
  December 9,288 (10.3%) 30 (11.0%)
History of Diabetes 24,027 (26.7%) 54 (19.9%)
History of CHD 24,028 (26.7%) 66 (24.3%)
History of heart failure 14,231 (15.8%) 36 (13.2%)
History of stroke 2,365 (2.6%) 12 (4.4%)
History of CKD 18,413 (20.4%) 47 (17.3%)
History of syncope 9,542 (10.6%) 33 (12.1%)
History of osteoporosis 18,591 (20.6%) 61 (22.4%)
History of depression 17,515 (19.4%) 70 (25.7%)



















in case period (N=272)
History of dementia 17,905 (19.9%) 68 (25.0%)
Number of medication classes
  0 – 5 18,085 (20.1%) 75 (27.6%)
  6 – 10 28,888 (32.1%) 90 (33.1%)
  >10 43,154 (47.9%) 107 (39.3%)
Charlson comorbidity index
    0 65,840 (73.1%) 167 (61.4%)
    1–3 11,945 (13.3%) 61 (22.4%)
    ≥ 4 12,342 (13.7%) 44 (16.2%)
Any hospitalization in the prior year 29,916 (33.2%) 126 (46.3%)
Skilled nursing facility stay in the prior
year
11,307 (12.5%) 54 (19.9%)
Data are expressed as number (percentage).
CHD = coronary heart disease, CKD = chronic kidney disease
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